Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

被引：1
|
作者：
Watanabe, J.
Horiguchi, J.
Masuda, N.
Aogi, K.
Sato, R.
Tokudome, T.
Peck, R. A.
机构：
[1] Shizuoka Canc Ctr, Shizuoka, Japan
[2] Gunma Univ, Sch Med, Maebashi, Gunma 371, Japan
[3] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[4] Natl Hosp Org Shikoku Canc Ctr, Eihme, Japan
[5] Bristol Myers Squibb KK, Tokyo, Japan
[6] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13095
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of BMS-247550 in combination with capecitabine in patients with metastatic breast cancer previously treated with a taxane and an anthracycline
    Thomas, E
    Bunnell, CA
    Vahdat, LT
    Schwartsberg, LS
    Gralow, JR
    Whitaker, LM
    Peck, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S83 - S83
  • [2] Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
    Sparano, Joseph A.
    Vrdoljak, Eduard
    Rixe, Oliver
    Xu, Binghe
    Manikhas, Alexey
    Medina, Carlos
    Ventilari Da Costa, Susanne Crocamo
    Ro, Jungsil
    Rubio, Gonzalo
    Rondinon, Monica
    Perez Manga, Gumersindo
    Peck, Ronald
    Poulart, Valerie
    Conte, Pierfranco
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3256 - 3263
  • [3] Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane
    Ahn, JH
    Kim, SB
    Kim, TW
    Ahn, SH
    Kim, SM
    Park, JM
    Lee, JS
    Kang, YK
    Kim, WK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 547 - 553
  • [4] Ixabepilone in patients (PTS) with metastatic breast cancer (MBC) that is resistant to an anthracycline, a taxane and capecitabine
    Pivot, Xavier
    Thomas, Eva
    Lerzo, Guillermo
    Bosserman, Linda
    Vahdat, Linda
    Cai, Can
    Mullaney, Brian
    Viens, Patrice
    Perez, Edith
    Hortobagyi, Gabriel N.
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 71
  • [5] Phase III trial of capecitabine (Xeloda®) plus bevacizumab (Avastin™) versus capecitabine alone in women with metastatic breast cancer (MBC) previously treated with an anthracycline and a taxane.
    Miller, KD
    Rugo, HS
    Cobleigh, MA
    Marcom, PK
    Chap, LI
    Holmes, FA
    Fehrenbacher, L
    Overmoyer, BA
    Reimann, JD
    Vassel, AV
    Langmuir, VK
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S37 - S37
  • [6] Phase I study of capecitabine in combination with paclitaxel in patients with previously treated metastatic breast cancer
    Villalona-Calero, M
    Blum, J
    Diab, S
    Elledge, R
    Khoury, P
    Kraynak, M
    Moczygemba, J
    Kromelis, P
    Impellizeri, K
    Griffin, T
    Von Hoff, D
    Rowinsky, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [7] Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane (vol 28, pg 3256, 2010)
    Sparano
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 947 - 947
  • [8] Ixabepilone plus capecitabine improves overall survival in symptomatic patients with metastatic breast cancer previously treated with anthracycline and taxane in 2 large phase III studies.
    Conte, P.
    Roche, H.
    Perez, E.
    Sparono, J.
    Xu, B.
    Jassem, J.
    Peck, R.
    Mukhopadhyay, P.
    Hortobagyi, G.
    CANCER RESEARCH, 2009, 69 (02) : 381S - 382S
  • [9] Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer
    Bunnell, Craig
    Vahdat, Linda
    Schwartzberg, Lee
    Gralow, Julie
    Klimovsky, Judith
    Poulart, Valerie
    Peck, Ronald
    Thomas, Eva
    CLINICAL BREAST CANCER, 2008, 8 (03) : 234 - 241
  • [10] Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
    Thomas, Eva S.
    Gomez, Henry L.
    Li, Rubi K.
    Chung, Hyun-Cheol
    Fein, Luis E.
    Chan, Valorie F.
    Jassem, Jacek
    Pivot, Xavier B.
    Klimovsky, Judith V.
    de Mendoza, Fernando Hurtado
    Xu, Binghe
    Campone, Mario
    Lerzo, Guillermo L.
    Peck, Ronald A.
    Mukhopadhyay, Pralay
    Vahdat, Linda T.
    Roche, Henri H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5210 - 5217
12345